Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GH NYSE:HIMS NASDAQ:RDNT NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$67.42+4.6%$51.69$20.14▼$67.51$8.41B1.432.82 million shs2.86 million shsHIMSHims & Hers Health$42.36-4.0%$49.98$13.47▼$72.98$9.57B2.0829.95 million shs16.08 million shsRDNTRadNet$71.760.0%$59.87$45.00▼$93.65$5.52B1.431.05 million shs627,715 shsWGSGeneDx$129.49+0.4%$100.03$28.86▼$130.91$3.72B2.02748,496 shs441,270 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health0.00%+9.80%+64.52%+65.45%+157.33%HIMSHims & Hers Health0.00%-4.87%-35.99%-25.34%+189.34%RDNTRadNet0.00%+2.37%+31.12%+24.20%+9.41%WGSGeneDx0.00%+0.65%+27.01%+83.13%+308.61%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGHGuardant Health3.2556 of 5 stars1.52.00.04.43.52.50.6HIMSHims & Hers Health3.2243 of 5 stars2.03.00.00.02.53.33.1RDNTRadNet3.2144 of 5 stars1.62.00.04.64.12.50.0WGSGeneDx2.0604 of 5 stars1.42.00.00.02.74.21.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.06Buy$57.50-14.71% DownsideHIMSHims & Hers Health 1.92Reduce$38.92-8.13% DownsideRDNTRadNet 3.25Buy$71.60-0.22% DownsideWGSGeneDx 2.75Moderate Buy$101.63-21.52% DownsideCurrent Analyst Ratings BreakdownLatest WGS, HIMS, GH, and RDNT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/19/2025HIMSHims & Hers HealthZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/18/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$48.00 ➝ $37.008/18/2025RDNTRadNetZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/13/2025RDNTRadNetRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingStrong-Buy ➝ Strong-Buy$66.00 ➝ $75.008/11/2025RDNTRadNetMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeOverweight8/5/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold8/4/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$110.00 ➝ $120.007/31/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$57.00 ➝ $60.007/31/2025GHGuardant HealthRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$59.00 ➝ $61.007/30/2025WGSGeneDxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$78.00 ➝ $95.007/17/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$45.00 ➝ $48.00(Data available from 8/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$739.02M11.38N/AN/A($2.45) per share-27.52HIMSHims & Hers Health$1.48B6.48$0.35 per share120.26$2.49 per share17.01RDNTRadNet$1.83B3.02$3.48 per share20.60$15.33 per share4.68WGSGeneDx$305.45M12.18$1.02 per share126.54$9.65 per share13.42Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$436.37M-$3.35N/AN/AN/A-49.93%N/A-28.95%11/5/2025 (Estimated)HIMSHims & Hers Health$126.04M$0.8052.9581.462.869.63%26.26%13.06%11/3/2025 (Estimated)RDNTRadNet$2.79M-$0.20N/A135.40N/A-0.78%2.41%0.82%11/10/2025 (Estimated)WGSGeneDx-$52.29M$0.052,589.8061.96N/A0.39%16.51%9.35%11/4/2025 (Estimated)Latest WGS, HIMS, GH, and RDNT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/10/2025Q2 2025RDNTRadNet$0.17$0.31+$0.14$0.43$488.06 million$498.23 million8/4/2025Q2 2025HIMSHims & Hers Health$0.18$0.17-$0.01$0.17$550.06 million$544.83 million7/30/2025Q2 2025GHGuardant Health-$0.52-$0.44+$0.08-$0.80$211.19 million$232.09 million7/29/2025Q2 2025WGSGeneDx$0.10$0.50+$0.40$0.36$86.00 million$102.69 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A3.713.35HIMSHims & Hers Health1.724.984.46RDNTRadNet0.912.002.00WGSGeneDx0.192.872.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%HIMSHims & Hers Health63.52%RDNTRadNet77.90%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipGHGuardant Health6.10%HIMSHims & Hers Health13.71%RDNTRadNet5.60%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health1,790124.71 million117.10 millionNot OptionableHIMSHims & Hers Health1,637226.02 million195.03 millionOptionableRDNTRadNet11,02176.92 million72.61 millionOptionableWGSGeneDx1,20028.73 million20.22 millionOptionableWGS, HIMS, GH, and RDNT HeadlinesRecent News About These CompaniesFORA Capital LLC Takes $420,000 Position in GeneDx Holdings Corp. $WGS2 hours ago | marketbeat.comTri Locum Partners LP Has $5.15 Million Holdings in GeneDx Holdings Corp. $WGSAugust 30 at 8:04 AM | marketbeat.comNext Century Growth Investors LLC Boosts Stake in GeneDx Holdings Corp. $WGSAugust 30 at 7:02 AM | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsAugust 29 at 2:06 PM | globenewswire.comWhy GeneDx Holdings (WGS) Is Up 7.4% After Fraud Allegations and Class Action Investigation NewsAugust 28 at 8:21 AM | finance.yahoo.com46,215 Shares in GeneDx Holdings Corp. $WGS Purchased by Jump Financial LLCAugust 28 at 6:14 AM | marketbeat.comGeneDx (NASDAQ:WGS) Shares Down 5.1% on Insider SellingAugust 27, 2025 | marketbeat.comGeneDx Holdings Corp. $WGS Shares Acquired by Wellington Management Group LLPAugust 27, 2025 | marketbeat.comRaymond James Financial Inc. Purchases 68,331 Shares of GeneDx Holdings Corp. $WGSAugust 27, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Stock Price Down 5.1% After Insider SellingAugust 27, 2025 | americanbankingnews.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSAugust 26, 2025 | prnewswire.com503,733 Shares in GeneDx Holdings Corp. $WGS Purchased by T. Rowe Price Investment Management Inc.August 26, 2025 | marketbeat.comGeneDx Holdings Corp. $WGS Shares Sold by Charles Schwab Investment Management Inc.August 26, 2025 | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsAugust 25, 2025 | globenewswire.comAmerican Century Companies Inc. Makes New Investment in GeneDx Holdings Corp. $WGSAugust 25, 2025 | marketbeat.comVanguard Group Inc. Buys 25,116 Shares of GeneDx Holdings Corp. $WGSAugust 25, 2025 | marketbeat.comROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSAugust 24, 2025 | markets.businessinsider.comGeneDx Holdings Corp. $WGS Shares Purchased by Swiss National BankAugust 24, 2025 | marketbeat.comGeneDx Holdings Corp. Stock (WGS) Opinions on 52-Week High and Q2 EarningsAugust 23, 2025 | quiverquant.comQGeneDx (NASDAQ:WGS) Director Sells $60,450,000.00 in StockAugust 23, 2025 | insidertrades.comGeneDx Holdings Corp. $WGS Shares Purchased by Algert Global LLCAugust 22, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesCatalysts Align: Archer Beats Estimates, Delivers Aircraft to UAEBy Jeffrey Neal Johnson | August 13, 2025Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyBy Jordan Chussler | August 9, 2025Oracle’s 2025 Rally Is Only Half Over: 5 Reasons WhyBy Thomas Hughes | August 11, 20255 High Short-Interest Stocks to Buy Before NovemberBy Thomas Hughes | August 20, 2025Amazon Stock Sets Up for Breakout After Bullish CrossoverBy Sam Quirke | August 21, 2025WGS, HIMS, GH, and RDNT Company DescriptionsGuardant Health NASDAQ:GH$67.42 +2.95 (+4.58%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$67.32 -0.10 (-0.15%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$42.36 -1.76 (-3.99%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$42.58 +0.23 (+0.53%) As of 08/29/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.RadNet NASDAQ:RDNT$71.76 -0.03 (-0.04%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$70.96 -0.80 (-1.11%) As of 08/29/2025 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.GeneDx NASDAQ:WGS$129.49 +0.49 (+0.38%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$129.50 +0.00 (+0.00%) As of 08/29/2025 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
